← Back to search

Small-Molecule Modulation of TDP-43 Recruitment to Stress Granules Prevents Persistent TDP-43 Accumulation in ALS/FTD.

Mark Y Fang, Sebastian Markmiller, Anthony Q Vu, Ashkan Javaherian, William E Dowdle, Philippe Jolivet, Paul J Bushway, Nicholas A Castello, Ashmita Baral, Michelle Y Chan, Jeremy W Linsley, Drew Linsley, Mark Mercola, Steven Finkbeiner, Eric Lecuyer, Joseph W Lewcock, Gene W Yeo

Neuron · 2019 · Vol. 103 (5) · pp. 802-819.e11

Abstract

Stress granules (SGs) form during cellular stress and are implicated in neurodegenerative diseases such as amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD). To yield insights into the role of SGs in pathophysiology, we performed a high-content screen to identify small molecules that alter SG properties in proliferative cells and human iPSC-derived motor neurons (iPS-MNs). One major class of active molecules contained extended planar aromatic moieties, suggesting a potential to intercalate in nucleic acids. Accordingly, we show that several hit compounds can prevent the RNA-dependent recruitment of the ALS-associated RNA-binding proteins (RBPs) TDP-43, FUS, and HNRNPA2B1 into SGs. We further demonstrate that transient SG formation contributes to persistent accumulation of TDP-43 into cytoplasmic puncta and that our hit compounds can reduce this accumulation in iPS-MNs from ALS patients. We propose that compounds with planar moieties represent a promising starting point to develop small-molecule therapeutics for treating ALS/FTD.

Funding 4 grants
Grant Funder
R01 HG004659 NHGRI NIH HHS (United States)
T32 DK007541 NIDDK NIH HHS (United States)
RF1 AG058476 NIA NIH HHS (United States)
RF1 AG056151 NIA NIH HHS (United States)